Laserfiche WebLink
State of Califomia-liealth and VWftne Agency <br />M..: F 1 � <br />13. Cont. <br />• • <br />Ame dnw t Number: 51 <br />(b) The letter with attachments dated October 7, 1994, signed by Michael N. Smith, Director, regarding <br />procedural changes and instruments calibration <br />(c) The letter with attachments dated November 21, 1994 signed by Steve Ebert, Hospital Director, regarding <br />the new Radiation Training module. <br />(d) The letter dated December 13, 1994, signed as 'ir, MD., reganting the use of Calicheck <br />device for the quartedy linearity test ofthe Dose calibrator. <br />14. (a) The Radiation Safety Officer in this program shall be�Douglas McGirr, NLD. <br />(b) The Chairperson of the Radiation Safety Committee shall be Douglas McGirr,NLD. <br />(c) The Custodian of sealed sources shall be Douglas NkGirr, NLD. <br />15. Sealed sources possessed under this license shall be tested for leakage and/or contamination as required by <br />Section 30275 (c) of the California Radiation Control Regulations. <br />16. Quantitative analytical assays for the purpose of tests for leakage and/or contamination of sealed sources shall <br />be performed only by persons specifically authorized to perform that service. <br />17. The following individuals are authorized to collect wipe test samples of sealed sources possessed under this <br />license using leak test kits acceptable to the California Department of Health Services: . <br />(a) the Radiation Safety Officer <br />(b) qualified individuals designated in writing by the Radiation Safety Officer <br />18. Records of leak test results shall be kept in units of microcuries and maintained for inspection Records may <br />be disposed of following Department inspection Any leak test revealing the presence of 0.005 microcuries <br />or more of removable radioactive material snail be reported to the Department of Health Services, Radiologic <br />Health Branch, 601 N. 7th Street P.O. Box 942732, Sacramento, CA 94234-7320, within five days of the test. <br />This report shall include a description of the defective source or device, the results of the test, and the <br />corrective action taken <br />19. Except as otherwise specifically provided by this license, radiopharmaceuticals to be administered to humans <br />shall be procured in prepackaged, precalibrated form from a supplier who is registered with the U. S. Food and <br />Drug Administration, or prepared and compounded, from a prescription, in accordance with the regulations of <br />the California Board of Pharmacy. <br />20. Except as otherwise specifically provided by this license, radioactive biologicals (including human serum <br />albumin) to be administered to humans shall be procured in prepackaged, precalibrated form from a supplier <br />who is licensed for the preparation and distribution of such products by the Division of Biologics Standards <br />of the National Institutes of Health, or U. S. Food and Drug Administration, or prepared in accordance with <br />the regulations of the California Board of Pharmacy. <br />21. Radioactive materials prepared, processed, or modified by the licensee shall not be administered to humans <br />except as specifically authorized by this license. <br />